Across
- 6. health products and services based on genetic developments (2 words)
- 7. damages awarded for mental anguish or suffering (2 words)
- 9. confidential communication protected by law
- 10. the stakeholder that funds programs like Medicare and Medicaid
- 11. the expectation that one acts as a reasonable person would under similar circumstances (3 words)
- 13. the minimum level of expected professional performance (3 words)
- 14. statutes defining an agency’s powers and procedures (2 words)
- 15. a legal document issued by the court requiring a defendant to respond
- 16. failure to act when action is required
- 19. damages awarded for harm resulting from an injury
- 22. the total value of goods and services produced in a country (3 words)
- 24. breach of duty of care
- 26. dispute resolution using a neutral third party to help reach agreement
- 28. a doctrine holding employers responsible for employees’ actions (2 words)
- 30. individuals or groups with a vested interest in health care
- 31. a legal obligation to provide care
- 32. a condition associated with increased risk of diabetes
- 33. the stakeholder responsible for licensing and certification (2 words)
Down
- 1. the science of how genes affect an individual’s response to drugs
- 2. the phase of a lawsuit in which a higher court reviews a case
- 3. profit-focused organizations that reimburse providers (3 words)
- 4. the obligation to treat patients appropriately (3 words)
- 5. using computer technology to develop drugs based on molecular structure (3 words)
- 8. technology used in managing health care information (3 words)
- 12. the study of changes in gene activity passed to future generations without altering DNA
- 17. companies that sell health care policies (2 words)
- 18. damages awarded to punish the defendant
- 20. the court of last resort (2 words)
- 21. the study of proteins expressed by genes
- 23. compensation for loss of estate and future earnings (2 words)
- 25. a written contract for health care coverage involving an insurer (2 words)
- 27. the amount of money stakeholders spend on health care
- 29. testimony taken under oath during the interrogatory phase
